Generic tacrolimus did not meet the bioequivalence criteria ; the area under the curve ( 0-12 ) ratio of generic-original tacrolimus formulation was 1.17 ( 90 % confidence interval , 1.10-1 .23 ) and the Cmax ratio was 1.49 ( 90 % confidence interval , 1.35-1 .65 ) .